Supplementation therapy and Benign oesophageal neoplasm

Summary:

Benign oesophageal neoplasm is reported only by a few people with Supplementation therapy.

The study analyzes which people have Benign oesophageal neoplasm with Supplementation therapy. It is created by eHealthMe based on 2 people who have Benign oesophageal neoplasm and Supplementation therapy from the Food and Drug Administration (FDA), and is updated regularly.

With medical big data and AI algorithms, eHealthMe enables everyone to run phase IV clinical trial to detect adverse drug outcomes and monitor effectiveness. Our original studies have been referenced on 600+ peer-reviewed medical publications including The Lancet, Mayo Clinic Proceedings, and Nature. Most recently, phase IV clinial trails for COVID 19 vaccines have been added, check here.



On May, 22, 2022

2 people who have Supplementation Therapy and Benign Oesophageal Neoplasm are studied.


What is Supplementation therapy?

Supplementation therapy is found to be associated with 44 drugs and 5 conditions by eHealthMe.

What is Benign oesophageal neoplasm?

Benign oesophageal neoplasm (benign (non-cancerous) tumours of the oesophageal) is found to be associated with 88 drugs and 47 conditions by eHealthMe.

Number of Benign oesophageal neoplasm in Supplementation therapy reports submitted per year:

Would you have Benign oesophageal neoplasm when you have Supplementation therapy?

Gender of people who have Supplementation Therapy and experienced Benign Oesophageal Neoplasm *:

  • female: 100 %
  • male: 0.0 %

Age of people who have Supplementation Therapy and experienced Benign Oesophageal Neoplasm *:

  • 0-1: 0.0 %
  • 2-9: 0.0 %
  • 10-19: 0.0 %
  • 20-29: 0.0 %
  • 30-39: 0.0 %
  • 40-49: 0.0 %
  • 50-59: 0.0 %
  • 60+: 100 %

Common co-existing conditions for these people *:

  1. Stress And Anxiety: 2 people, 100.00%
  2. Pain: 2 people, 100.00%
  3. Nausea (feeling of having an urge to vomit): 2 people, 100.00%
  4. Lung Cancer - Non-Small Cell (lung cancer): 2 people, 100.00%

Common drugs taken by these people *:

  1. Proair Hfa: 2 people, 100.00%
  2. Prilosec: 2 people, 100.00%
  3. Potassium: 2 people, 100.00%
  4. Magnesium: 2 people, 100.00%
  5. Gilotrif: 2 people, 100.00%
  6. Gaviscon: 2 people, 100.00%
  7. Claritin: 2 people, 100.00%

Common symptoms for these people *:

  1. Weight Increased: 2 people, 100.00%
  2. Weight Decreased: 2 people, 100.00%
  3. Anal Ulcer: 2 people, 100.00%
  4. Blood Potassium Decreased: 2 people, 100.00%
  5. Blood Urine Present: 2 people, 100.00%
  6. Breathing Difficulty: 2 people, 100.00%
  7. Constipation: 2 people, 100.00%
  8. Diarrhea: 2 people, 100.00%
  9. Dry Skin: 2 people, 100.00%
  10. Flatulence (flatus expelled through the anus): 2 people, 100.00%

* Approximation only. Some reports may have incomplete information.

Do you take medications and have Benign oesophageal neoplasm?

Check whether Benign oesophageal neoplasm is associated with a drug or a condition

How to use the study?

You can discuss the study with your doctor, to ensure that all drug risks and benefits are fully discussed and understood.



Related studies

Treatments, associated drugs and conditions:

COVID vaccines that are related to Benign oesophageal neoplasm:

All the drugs that are associated with Benign oesophageal neoplasm:

All the conditions that are associated with Benign oesophageal neoplasm:

How the study uses the data?

The study is based on Benign oesophageal neoplasm and Supplementation therapy, and their synonyms.

Who is eHealthMe?

With medical big data and proven AI algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 600+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.

Recent studies on eHealthMe: